Introduction: Quercetin is a polyphenolic flavonoid which has been used in traditional Chinese medicine as a natural therapeutic agent with a broad spectrum of activities (antioxidant, anticancer, neuroprotective, anti-inflammatory, antiviral and antibacterial). The aim of this study was to develop and validate a rapid and simple ultra-high-performance liquid chromatography with tandem mass spectrometry (UHPLC-MS/MS) method for the determination of quercetin in milk. Material and Methods: Sample preparation was based on a liquid-liquid extraction with 0.5% formic acid in acetonitrile. The chromatographic separation was performed on a ZORBAX SB-C18 column with methanol and 0.5% formic acid as a mobile phase. Results: The procedure was successfully validated. The mean recovery of the analyte was 98%, with the corresponding intra-and inter-day variation less than 10% and 15%, respectively, and the repeatability and reproducibility were in the range of 3%-7.2% and 6.1%-12%, respectively. The lowest level of quantification was 1.0 μg/kg. Conclusion: The proposed method was successfully applied in evaluating the pharmacokinetics of quercetin in milk obtained from dairy cows with clinical mastitis after intramammary administration.
Introduction
Quercetin belongs to the flavonol group of flavonoids, which are natural compounds occurring in photosynthesising cells in plants. Flavonoids are of great interest, because of their various pharmacological effects (antioxidant, anticancer, neuroprotective, antiinflammatory, antiviral, and antibacterial). Due to their broad spectrum of biological activities, plant extracts containing these compounds are successfully used to treat various human diseases. In the era of prevention of more bacterial resistance to antibiotics both in humans and animals, searching for new alternative treatments is a particularly vital undertaking. Reducing the use of antimicrobial drugs is one of the most important challenges in medicine, and in this endeavour Quercetin may have great importance for veterinary medicine. In the case of mastitis, which is a major endemic disease of dairy cows manifesting as inflammation of the mammary gland, antibiotic therapy reduction is very desirable. Because of its antibacterial activities, quercetin may be used in mastitis treatment as an alternative to antibiotics. However, to carry out research into the expediency of the treatment, it is necessary to have an appropriate analytical method which allows quercetin content in milk samples to be assayed. In the literature, there are some reports describing the determination of quercetin in biological samples, but most of them focus on its determination in rat plasma or plant products (1-3, 7, 9, 10) . There is no published assay for the analysis of the flavonoid in milk samples. So far, quercetin antibacterial properties against different microorganisms have been tested in humans (4, 8, 11) . Its pharmacokinetics have also been completely evaluated in humans (5, 6) , but for animals there are only a few papers, mostly concerning rats (1, 2, 7, 9) . The pharmacokinetic profile of any flavonoid in milk from dairy cows with mastitis has not been described so far.
In this study, we developed a quantitative analytical method for the determination of quercetin in milk samples. The method was further applied for the estimation of pharmacokinetic parameters of quercetin in milk samples and could be helpful for evaluating the application of quercetin in dairy cow mastitis therapy.
Material and Methods
Reagents. All reagents used were of an analytical grade. Acetonitrile, methanol, and formic acid were obtained from J.T. Baker (Deventer, the Netherlands). Water was deionised (>18 MΩ cm −1 ) by the Millipore system (Merck, Germany). Quercetin and sulphaphenazole (an internal standard -IS) were purchased from Sigma Aldrich (USA). Polyvinylidene fluoride (PVDF) syringe filters of 0.22 μm size were from Restek (USA).
Chromatography and mass spectrometry. The quercetin concentration in milk was determined using a Nexera X2 ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) (Shimadzu, Japan) system connected to a QTRAP 4500 triple quadrupole mass spectrometer (AB Sciex, USA). Analyst 1.6.3 software (AB Sciex) controlled the UHPLC-MS/MS system and processed the data. The chromatography separation was performed on a ZORBAX SB-C18 column (50 mm × 2.1 mm × 1.8 µm) (Agilent, USA) integrated with a guard column of the same type. The mobile phase for analysis consisted of methanol (A) and 0.5% formic acid (B). Gradient elution was performed as follows: 0.0-2.0 min (15% A), 2.01-3.3 min (80% A), and 3.31-5.0 min (15% A) at a flow rate of 0.5 ml/min and injection volume of 5 µl. Detection was performed in the negative ionisation mode in the selected reaction monitoring mode (SRM). The transitions m/z 301 > 151 and 301 > 178 for quercetin and 313 > 156 for the IS were monitored.
Preparation of standards and quality control samples. A stock solution of quercetin (1 mg/ml) was prepared in acetonitrile and stored in an amber volumetric flask at −18°C for no longer than two months, and a working standard solution (1µg/mL) was prepared in water and stored in a plastic flask at 4°C for no longer than one week. A stock IS solution (1 mg/mL) was prepared in water and stored in an amber volumetric flask at −18°C for no longer than six months, and a working solution (1 µg/mL) was prepared in deionised water and stored in an amber volumetric flask at 4°C for no longer than one month. Quality control (QC) samples were prepared by spiking blank milk samples at three concentration levels (10, 100, and 1,000 µg/kg) for the validation process and at six concentration levels (1, 10, 100, 1,000, 5,000 and 10,000 µg/kg) during routine real sample analysis.
Milk samples preparation. Milk (500 mg) was weighed in a 1.5 mL microcentrifuge tube, then 50 µL of IS and 1 mL of 0.5% formic acid in acetonitrile were added, mixed, and centrifuged at 9,447 × g for 5 min at room temperature. Supernatant was filtered through a 0.22 µm PVDF syringe filter into chromatographic vials.
Validation method. The linearity, selectivity, repeatability, reproducibility, recovery, lower limit of quantification (LLOQ), and matrix effect (ME) of the method were evaluated. The linearity was determined by the matrix-matched calibration curve which was prepared by fortifying blank milk samples at 10 concentration levels (1-10,000 µg/kg). IS in a 50 μL volume was added to each sample. Quantitative results of evaluation were obtained by comparing the analyte/IS peak area ratio from a matrix-matched calibration curve to the analyte/IS peak area ratio in analysed samples. Selectivity was checked by analysis of 20 blank milk samples collected from different sources which allows the possible presence of interfering substances to be verified around the retention times of the compounds of interest.
The repeatability was calculated as the relative standard deviation (RSDr, %) of results obtained after fortifying six blank milk samples at three concentration levels (10, 100, and 1,000 µg/kg). The spiked samples were prepared and analysed on the same day with the same instrument and the same operators. The withinlaboratory reproducibility was calculated as the RSDr of the results obtained after fortifying another two sets of blank samples at the same concentration levels of analysed compounds as for the repeatability and analysing them on two different days with the same instrument and different operators.
The average recovery was evaluated in the same experiment as repeatability by comparing the mean measured concentration with the fortified concentration of the samples in relation to matrix-matched calibration curve. Validation also needed the LLOQ, and it was defined as the lowest concentration on the calibration curve determined at a signal-to-noise (S/N) of 10.
Completing validation, the ME was evaluated as the ratio of analyte peak area added into postextracted blank milk samples to the IS peak area in water at corresponding concentrations (10, 100, and 1,000 µg/kg).
Application. The animal study was conducted with the consent of the Local Ethical Committee for Animal Experiments in Lublin (33/2017). Based on a somatic cell count (SCC > 300,000 cells/ml) and clinical investigation, nine dairy cows with clinical mastitis in one quarter were selected. The animals were of Polish Black-and-White breed, weighed 700 kg each, and were 4-12 years of age. Analysis of quercetin pharmacokinetics was performed after a single intramammary dose of 10 mg/quarter. Milk samples (5 mL) were collected into plastic tubes at 5 and 15 min, and 4, 6, 8, 12, 24, 36, 48, 72, 96, 120, 144, 168, and 192 h after quercetin administration. The samples were frozen at −20°C until analysis.
The pharmacokinetic investigation of quercetin was performed using Phoenix WinNonlin 7.0 (Certara, USA) and ThothPro 4.1 (ThothPro, Poland) software. SHAM analysis was based on the slope, height, and area. The area under the curve calculated between zero and the last sampling point (AUC0−t), the area under the first moment curve calculated between zero and the last sampling point (AUMC0−t), the mean residence time calculated for the last sampling point (MRT0−t), the elimination halflife (t1/2kel), the elimination rate constant (kel), the maximal concentration (Cmax), the elimination half-life based on MRT0−t (t1/2MRT) and calculated using the equation t1/2MRT = Ln(2)/(1/MRT0−t), the volume of distribution in steady state (Vss), and the clearance (CL) were determined.
Results
The chromatograms of the blank milk samples and those fortified at 10 µg/kg concentration are shown in Fig. 1 .
The matrix-matched calibration curves showed good linearity (r 2 > 0.997) over the range of 10-10,000 µg/kg for quercetin. The selectivity of the method was found to be satisfactory with no interfering peaks from endogenous compounds in the retention time of the target analyte in milk samples. The method was repeatable since the RSDr was in the range of 3%-7.2%, and RSDwR ranged from 6.1% to 12% for all investigated concentration levels for quercetin in milk samples. Satisfactory average recoveries were obtained and ranged from 89.1% to 108%, depending on the concentration levels. The LLOQ of the method for quercetin was calculated as 1.0 µg/kg. The ME was 2.6%, 1.8%, or 2.8%, depending on the quercetin concentration level. The results indicate that ME does not affect the determination of quercetin in milk samples.
The developed method was successfully applied for the determination of quercetin in milk samples. The concentration-time profile is shown in Fig. 2 .
The calculated values of selected pharmacokinetic parameters were as follow: AUC0−t 31.64 ± 17.04 µg × h/g, AUMC0−t −1,904.47 ± 903.10 µg × h 2 /g, MRT0−t 67.4 ± 25.77 h, t1/2MRT 46.72 ± 17.86, t1/2kel 3.89 ± 2.66 h, kel 0.245 ± 0.135 1/h, Cmax 2.80 ± 3.54 µg/g, Vss 29.94 ± 21.15 l, and CL 0.402 ± 0.207 h −1 . Every ≈65 h after single administration, a fluctuation of quercetin concentrations was observed. The equable decrease in quercetin concentrations in the late elimination phase could indicate a twocompartmental model of its distribution in udder tissue. However, the decrease and increase in the concentration exclude the compartmental theory.
Discussion
The UHPLC conditions were investigated to elicit how to best separate interfering compounds in a short runtime, and the mass spectrometer parameters were optimised to receive better resolution. The following values were chosen: 90 and 100 V declustering potential, 27 and 33 V collision energy, and 13 and 15 V cell exit potential for quercetin and sulphaphenazole, respectively. These settings resulted in a high intensity peak for both compounds and good linearity in the regression of the calibration curves. Several mobile phases including a combination of acetonitrile, methanol, and water with or without acid were tested. Using the mixture of methanol and 0.5% formic acid resulted in the most effective separation and the best peak shapes of analytes. Various conditions of liquid-liquid extraction (LLE) were tested for isolation of quercetin from milk samples to achieve the most effective extraction procedure: acetonitrile, acetonitrile with acids (formic acid, acetic acid, and citric acid), and methanol with acetonitrile. The outcome was finding an extraction mixture of 0.5% formic acid in acetonitrile followed by 0.22 µm syringe filtration suitable to allow effective protein denaturation and elimination of undesirable compounds from the extract.
The present study is the first to describe the pharmacokinetics of quercetin in milk samples collected from dairy cows with mastitis. The mean concentration of quercetin in milk samples decreases rapidly after administration. Most of the evaluated parameters show high individual variability, where for example for Cmax it is over 120%, and for AUC0−t it is over 50%. Because of the fast decline of quercetin concentration in milk, the t1/2kel is very short. It is not possible to precisely define this parameter because of fluctuations of the concentration in the late elimination phase. Therefore, the MRT0−t parameter, which in this study is much longer than t1/2kel, can be a substitute for the presentation of the elimination phase.
In conclusion, a sensitive, selective, and rapid method for quantification of quercetin in milk samples was developed. The method was validated and applied in the determination of quercetin concentration in milk after experimental administration. Such an analytical method, suitable for the determination of quercetin levels for calculations of its pharmacokinetics in milk samples, is reported for the first time.
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